Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Recruiting · NCT07335211 · Interventional (participants receive a specific treatment) · Lead sponsor: Huons Co., Ltd.
View the official record on ClinicalTrials.gov →Interventions studied
HUC3-637HUC3-637-R
What this trial is about
A multicenter, randomized, single-blind, active controlled, phase III clinical trial to evaluate the efficacy and safety of HUC3-637 in patients with primary open angle glaucoma or ocular hypertension
Who can take part
Age range
19 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Adults aged 19 years and older
- Participants diagnosed with POAG or OH
- Have fully explained and understood the study and have voluntarily given written informed consent.
Exclusion criteria
- Acute or chronic angle-closure glaucoma
- Congenital glaucoma, secondary glaucoma (open-angle glaucoma)
Where it is running
1 location listed.
- Kangbuk Samsung Hospital - Seoul, South Korea